I now have sufficient information from Goldman-Cecil Medicine and Campbell's Operative Orthopaedics, combined with the web sources, to give a comprehensive clinical answer on chronic triceps tendinitis/tendinopathy. Let me compile the full response.
Chronic Tendinitis (Tendinopathy) of the Triceps Tendon
Overview and Terminology
Triceps tendinopathy is among the rarest tendinopathies around the elbow, listed as a sports-related condition in Goldman-Cecil Medicine alongside Little League elbow and distal biceps tendinosis. The older term "tendinitis" implied a primarily inflammatory process, but current understanding classifies chronic triceps tendinopathy as a failed healing response - a degenerative process (tendinosis) rather than true ongoing inflammation. This distinction matters clinically: long-term success comes from re-loading and rehabilitating the tendon, not simply suppressing inflammation.
The condition is listed under sports medicine injuries in Goldman-Cecil Medicine, p. 2776.
Anatomy
The triceps brachii has three heads (long, medial, lateral), all converging into a single broad, flat tendon that inserts onto the posterior olecranon of the ulna. The medial head has a deep tendon beneath the common tendon. The distal tendon has a defined footprint on the proximal ulna near the subcutaneous border (Campbell's Operative Orthopaedics, 15th ed., 2026).
Tendinopathy typically affects the insertional portion at the olecranon, though mid-substance changes can also occur.
Pathophysiology
In chronic overuse, repeated tensile loading without adequate recovery leads to:
- Disruption of collagen fiber architecture (collagen disarray)
- Increased ground substance and glycosaminoglycans (mucoid degeneration)
- Neovascularization (angiofibroblastic hyperplasia)
- Relative hypoxia at the enthesis
- Absent or sparse inflammatory infiltrate on histology
This is sometimes called angiofibroblastic tendinosis - the same pathology seen in lateral epicondylalgia and patellar tendinopathy.
Associations with tendinopathy/rupture include:
- Fluoroquinolone antibiotics (e.g., ciprofloxacin) - a recognized pharmacological risk
- Corticosteroid injections - associated with tendon weakening and rupture risk (Stannard & Bucknell, Am J Sports Med, 1993)
- Hemodialysis/hyperparathyroidism - secondary hyperparathyroidism predisposes to tendinitis in dialysis patients (Rheumatology Textbook, 2022)
- Anabolic steroid use
- Repetitive heavy pushing/pressing activities (bench press, overhead press, triceps dips, skull crushers)
Clinical Presentation
Symptoms:
- Posterior elbow pain localized to the olecranon insertion or just proximal to it
- Pain worsens with resisted elbow extension (push-ups, bench press, dips, throwing)
- Morning stiffness and stiffness after rest ("warm-up phenomenon")
- Weakness in elbow extension
- In severe cases, pain at rest
Signs:
- Tenderness on palpation over the triceps tendon insertion at the olecranon
- Pain reproduced with resisted elbow extension against resistance
- Possible palpable tendon thickening or nodularity
- No significant swelling or warmth (distinguishes from acute bursitis)
- Pain may be reproduced with passive full elbow flexion (stretching the tendon)
Differential Diagnosis
| Condition | Key Distinguishing Feature |
|---|
| Olecranon bursitis | Discrete bursal swelling at the tip of the elbow; minimal pain with motion |
| Triceps tendon partial/complete rupture | Palpable defect, sudden onset, loss of extension strength |
| Posterior impingement syndrome | Pain at full extension, osteophyte on imaging |
| Medial/lateral epicondylalgia | Pain at epicondyle, not at olecranon |
| Ulnar nerve (cubital tunnel) | Paresthesia in ring/little finger, positive Tinel's |
| Radial head pathology | Lateral elbow, pain with forearm rotation |
Investigations
Clinical diagnosis in most cases. Imaging is confirmatory and used to grade severity and rule out differential diagnoses.
- X-ray: May show calcific deposits at the olecranon insertion (enthesophyte, calcific tendinopathy), posterior osteophytes
- Ultrasound: First-line imaging - shows tendon thickening, hypoechoic foci (degeneration), intratendinous calcification, neovascularity on Doppler; can also detect partial tears and guide injections
- MRI: Gold standard for soft tissue detail - demonstrates tendon signal change, partial tears, bone marrow edema at enthesis; preferred if surgery is being considered
- No role for routine blood work unless systemic cause is suspected (inflammatory arthropathy, metabolic disease)
Management
1. Conservative (First-Line)
Load management and activity modification:
- Avoid provocative activities (heavy pushing, dips, skull crushers) in the acute flare
- Relative rest, not complete rest - complete immobilization worsens tendinopathy
Physical therapy - progressive tendon loading (cornerstone of treatment):
- Isometric exercises first - low-load, pain-inhibiting (e.g., resisted extension against a wall at mid-range, held 30-45 seconds)
- Isotonic/heavy slow resistance - eccentric and concentric loading with slow tempo
- Eccentric exercises - gradual controlled lengthening under load; graded increase in range of motion
- Progressive return to function over 8-12 weeks
- Address kinetic chain: scapular stability, thoracic mobility, shoulder rotation
Physical modalities:
- Ice/cryotherapy post-exercise to reduce reactive pain
- Heat before exercise to improve tissue extensibility
- RICE (rest, ice, compression, elevation) for acute flares - Goldman-Cecil, p. 2776
Pharmacological:
- NSAIDs (ibuprofen, naproxen): short-term pain control, limited effect on tendon healing long-term
- Topical NSAIDs (diclofenac gel): adjunct with fewer systemic effects
Orthotic/bracing:
- Elbow strap or forearm band to offload the insertion (limited evidence for triceps specifically vs. lateral epicondylalgia)
Extracorporeal shock wave therapy (ESWT):
- Evidence established for calcific tendinopathy (shoulder) and patellar/Achilles tendinopathy; some benefit reported for refractory insertional tendinopathy
- May be considered in chronic refractory cases (Goldman-Cecil, p. 2778 references ESWT for calcific tendinitis)
Corticosteroid injection:
- Used cautiously or avoided for triceps specifically
- May reduce pain short-term, but is associated with tendon weakening and rupture risk - especially relevant at the triceps where the literature documents rupture following steroid injections (Stannard & Bucknell, Am J Sports Med 1993; referenced in Campbell's)
- Generally not recommended as a routine intervention for chronic triceps tendinopathy
PRP (Platelet-Rich Plasma):
- Biologic approach with mixed evidence across tendinopathies
- No strong evidence specifically for triceps tendinopathy
- May be considered in stubborn, refractory cases under specialist supervision
2. Surgical (Reserved for Refractory Cases)
Indications:
- Failure of 6+ months of well-structured conservative rehabilitation
- High-grade partial tears on imaging
- High-demand athletes with persistent functional deficit
- Associated pathology (posterior osteophyte, olecranon spur)
Surgical options:
- Debridement/tenotomy - open or ultrasound-guided minimally invasive (Tenex procedure / percutaneous needle tenotomy) to excise degenerate tissue and stimulate healing response
- Tendon repair - for partial tears, using suture anchors to restore footprint contact at the olecranon
- Resection of calcific deposits or enthesophytes
- Postoperative rehabilitation follows the same progressive loading principles but with a longer initial protection phase
Prognosis
Good to excellent outcomes with well-structured conservative management. Most patients respond within 3-6 months of consistent rehabilitation. Chronic cases improve when loading errors are corrected and kinetic chain deficits are addressed. Key predictors of poor outcome include:
- Continued provocative loading without modification
- Use of corticosteroid injection
- Inadequate rehabilitation adherence
- Associated metabolic conditions (hyperparathyroidism, fluoroquinolone use)
If untreated or mismanaged, chronic tendinopathy can progress to partial or complete tendon rupture, which requires surgical repair and prolonged recovery.
Summary Table
| Domain | Key Points |
|---|
| Pathology | Angiofibroblastic tendinosis; failed healing, not active inflammation |
| Location | Insertional (olecranon) > mid-substance |
| Diagnosis | Clinical + ultrasound or MRI |
| First-line treatment | Load management + progressive strengthening |
| Medication | NSAIDs short-term; avoid steroids in tendon |
| Injection | Corticosteroids used with caution (rupture risk); PRP investigational |
| Surgery | Rare; debridement/tenotomy or repair for refractory cases |
| Prognosis | Good with structured rehab |
Sources:
- Goldman-Cecil Medicine, International Edition (2022/Elsevier), Chapter 242 - Sports Medicine Injuries & Disorders of the Elbow
- Campbell's Operative Orthopaedics, 15th ed. (2026), Chapter 76 - Rupture of Biceps Brachii and Triceps Tendons
- Rheumatology, 2-Volume Set (2022, Elsevier) - tendinopathy in dialysis/metabolic disease
- Tom JA, et al. "Diagnosis and treatment of triceps tendon injuries: a review." Clin J Sport Med. 2014;24:197 (cited in Campbell's)
- Stannard JP, Bucknell AL. "Rupture of the triceps tendon associated with steroid injections." Am J Sports Med. 1993;21:482 (cited in Campbell's)